Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/7917366

Download in:

View as

General Info

PMID
7917366